Announcements
- Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
- Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
- 1st Quarter Results
- Burning Rock Reports First Quarter 2024 Financial Results
- BNR Schedules 2024 Q1 Earnings Release on May 29
- Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024
- BNR Announces ADS Ratio Change to Be Effective
- Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
- Burning Rock ADS Ratio Change
- BNR Publishes 2023 Annual Report on Form 20-F
More ▼
Key statistics
As of last trade Burning Rock Biotech Ltd (BNR:LSE) traded at 7.15, 0.00% above its 52-week low of 7.15, set on May 31, 2024.
52-week range
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 7.15 |
Average volume | 1.00 |
---|---|
Shares outstanding | 1.03m |
Free float | -- |
P/E (TTM) | -- |
Market cap | 78.29m USD |
EPS (TTM) | -64.76 USD |
Data delayed at least 15 minutes, as of May 31 2024 15:04 BST.
More ▼